Roche is at the forefront of efforts to advance the diagnosis and treatment of viral diseases, such as influenza and hepatitis.
Our diagnostic tests enable more precise measurement of the amount of virus in the blood, which helps physicians provide individualised solution for their patients.
Our medicines provide effective treatments – and often cures – while molecules in our pipeline may offer the promise of cures for even more patients.
Attached media information for this topic
|Frequently asked questions on data transparency and Tamiflu||Link|
|Tamiflu EU patient information leaflet|
|Understanding Hepatitis B|
|Understanding Hepatitis C|
|PEGASYS and COPEGUS Combination Therapy|